Interserve has been awarded a contract with The Christie NHS Foundation Trust to design, construct and co-ordinate a UK high energy Proton Beam Therapy facility.

Subject to approval, construction work is planned to start on site in 2016, completing in 2018. The project is part of a ProCure 21+ framework, with Interserve appointed Principal Supply Chain Partner.

Proton beam therapy is a specialist form of radiotherapy which can very precisely target certain cancers, increasing success rates and reducing side-effects. Its introduction to the UK will bring the treatment closer to patients who currently have to travel abroad to receive it.


The team, consisting of HKS Architect, ARUP Engineers and Gleeds Cost Consultants, will draw on their experience and research to deliver Proton Beam Therapy in the UK. Over a two year period, Interserve travelled to various sites internationally to capture experience and lessons learnt from similar facilities, talking to clinicians and contractors, in order to enable a local team to deliver what the client required.

Currently, Interserve and its partners are supporting and responding to specialist equipment vendors to provide concept designs. By designing the facility around the equipment, and being brought in so early in the equipment procurement stage, Interserve is helping The Christie to drive the project’s costs down and offer value for money. Full Level 2 BIM is being used throughout this design process. With the Department of Health requiring BIM Level 2 by 2016, Interserve is pioneering this approach ahead of the deadline.

The new Proton Beam Therapy facility builds on Interserve’s relationship with The Christie. Construction partners for over five years, The Christie and Interserve are committed to a further five years’ collaborative working to deliver best value projects with the finest clinical outcomes for patients.

(CD)